BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33997162)

  • 1. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma.
    Wang D; Chen F; Zeng T; Tang Q; Chen B; Chen L; Dong Y; Li X
    Genes Dis; 2021 Mar; 8(2):157-167. PubMed ID: 33997162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma.
    Niu ZS; Wang WH; Dong XN; Tian LM
    World J Gastroenterol; 2020 Aug; 26(29):4240-4260. PubMed ID: 32848331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma.
    Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT
    Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs.
    Zhang L; Wang C; Lu X; Xu X; Shi T; Chen J
    Front Oncol; 2022; 12():927524. PubMed ID: 36132143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Coding RNAs and Endometrial Cancer.
    Vallone C; Rigon G; Gulia C; Baffa A; Votino R; Morosetti G; Zaami S; Briganti V; Catania F; Gaffi M; Nucciotti R; Costantini FM; Piergentili R; Putignani L; Signore F
    Genes (Basel); 2018 Mar; 9(4):. PubMed ID: 29596364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
    Han TS; Hur K; Cho HS; Ban HS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
    Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
    Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs and hepatocellular carcinoma.
    Yu FJ; Zheng JJ; Dong PH; Fan XM
    Mol Clin Oncol; 2015 Jan; 3(1):13-17. PubMed ID: 25469263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
    Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction and cross-talk between non-coding RNAs.
    Yamamura S; Imai-Sumida M; Tanaka Y; Dahiya R
    Cell Mol Life Sci; 2018 Feb; 75(3):467-484. PubMed ID: 28840253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging landscape of long non-coding RNAs in hepatocellular carcinoma.
    Zhu Y; Xu G; Han C; Xing G
    Int J Clin Exp Pathol; 2021; 14(9):920-937. PubMed ID: 34646411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma].
    Kushlinskii NE; Fridman MV; Braga EA
    Mol Biol (Mosk); 2020; 54(5):776-801. PubMed ID: 33009789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.